Merck/Intervet/Schering-Plough Animal Health is a global, research-driven company that develops, manufactures and markets a broad range of veterinary medicines and services. We offer one of the industry’s most innovative portfolios, spanning products for the prevention, treatment and control of disease in all major farm and companion animal species.
Merck Animal Health, known as MSD Animal Health outside the United States and Canada, is the global animal health business unit of Merck.
Merck's animal health division, formerly known as Intervet/Schering-Plough Animal Health, announced that it has adopted the name of its parent company and will now be called Merck Animal Health.
It is the world leader in pharmaceuticals and vaccines for aquaculture and major products in its portfolio are the antibiotic AQUAFLOR (florfenicol), the parasiticide SLICE (emamectin benzoate) and the vaccine ranges AQUAVAC and NORVAX. The company is based in Boxmeer, The Netherlands.
We are a highly proactive, robust and diversified company with a strong, scientifically-proven, product portfolio and an ever-growing global reach.
With offices in more than 50 countries, we successfully market our products in over 140 countries and operate a network of manufacturing sites and research and development (R&D) facilities around the world.
What Will We Have if Cod Fails Us? Norway
For thousands of years, the skrei—a migratory cod—has journeyed over 1,000 kilometers from the Barents Sea to spawn along the coast of Northern Norway. This remarkable fish has been the li...
Pacific Saury Stocks Show Concerning Decline Japan
The Scientific Committee of the North Pacific Fisheries Commission (NPFC) has recommended a 10% reduction in the Total Allowable Catch (TAC) for Pacific saury in 2025.
This measure aims to allevi...
Copyright 1995 - 2025 Seafood Media Group Ltd.| All Rights Reserved. DISCLAIMER
Merck Animal Health - MSD Animal Health (former Intervet International)
Branches:
Main Company:
Subsidiaries:
Shareholder/Associate at:
Print
